A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Incyte Corp stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 192,442 shares of INCY stock, worth $13.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
192,442
Previous 214,183 10.15%
Holding current value
$13.6 Million
Previous $13 Million 2.03%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $1.25 Million - $1.49 Million
-21,741 Reduced 10.15%
192,442 $12.7 Million
Q2 2024

Aug 08, 2024

SELL
$51.18 - $63.75 $4.11 Million - $5.12 Million
-80,275 Reduced 27.26%
214,183 $13 Million
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $256,567 - $302,118
-4,537 Reduced 1.52%
294,458 $16.8 Million
Q4 2023

Feb 09, 2024

BUY
$52.16 - $64.19 $2.97 Million - $3.65 Million
56,848 Added 23.48%
298,995 $18.8 Million
Q3 2023

Nov 09, 2023

BUY
$57.77 - $65.93 $839,167 - $957,699
14,526 Added 6.38%
242,147 $14 Million
Q2 2023

Aug 08, 2023

SELL
$60.95 - $75.51 $192,541 - $238,536
-3,159 Reduced 1.37%
227,621 $14.2 Million
Q1 2023

May 10, 2023

BUY
$70.23 - $86.01 $1.3 Million - $1.6 Million
18,569 Added 8.75%
230,780 $16.7 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $683,556 - $855,819
10,175 Added 5.04%
212,211 $17 Million
Q3 2022

Nov 10, 2022

SELL
$66.18 - $82.86 $5.74 Million - $7.19 Million
-86,749 Reduced 30.04%
202,036 $13.5 Million
Q2 2022

Aug 09, 2022

BUY
$66.18 - $83.18 $6.12 Million - $7.69 Million
92,442 Added 47.08%
288,785 $21.9 Million
Q1 2022

May 12, 2022

SELL
$66.02 - $79.71 $470,128 - $567,614
-7,121 Reduced 3.5%
196,343 $15.6 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $4.28 Million - $5 Million
67,525 Added 49.67%
203,464 $14.9 Million
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $1.3 Million - $1.6 Million
19,001 Added 16.25%
135,939 $9.35 Million
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $706,609 - $774,377
-8,847 Reduced 7.03%
116,938 $9.84 Million
Q1 2021

May 12, 2021

SELL
$76.02 - $100.5 $2.54 Million - $3.36 Million
-33,439 Reduced 21.0%
125,785 $10.2 Million
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $528,927 - $640,032
6,551 Added 4.29%
159,224 $13.8 Million
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $190,897 - $246,144
2,244 Added 1.49%
152,673 $13.7 Million
Q2 2020

Sep 11, 2020

SELL
$74.18 - $108.93 $34.3 Million - $50.4 Million
-462,924 Reduced 75.47%
150,429 $15.6 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $33.9 Million - $49.8 Million
457,414 Added 293.33%
613,353 $15.6 Million
Q1 2020

May 13, 2020

BUY
$63.18 - $85.97 $287,911 - $391,765
4,557 Added 3.01%
155,939 $11.4 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $999,333 - $1.31 Million
13,682 Added 9.94%
151,382 $13.2 Million
Q3 2019

Nov 12, 2019

SELL
$72.82 - $86.52 $294,265 - $349,627
-4,041 Reduced 2.85%
137,700 $10 Million
Q2 2019

Aug 07, 2019

BUY
$73.52 - $88.7 $156,965 - $189,374
2,135 Added 1.53%
141,741 $12 Million
Q1 2019

May 13, 2019

BUY
$63.56 - $88.17 $355,936 - $493,752
5,600 Added 4.18%
139,606 $12 Million
Q4 2018

Feb 12, 2019

SELL
$58.5 - $69.94 $51,889 - $62,036
-887 Reduced 0.66%
134,006 $8.52 Million
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $14.3 Million - $17.2 Million
-231,102 Reduced 63.14%
134,893 $9.32 Million
Q2 2018

Aug 10, 2018

SELL
$60.85 - $83.98 $616,958 - $851,473
-10,139 Reduced 2.7%
365,995 $24.5 Million
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $2.34 Million - $2.84 Million
28,160 Added 8.09%
376,134 $31.3 Million
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $115,078 - $143,418
1,230 Added 0.35%
347,974 $33 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $37.8 Million - $47.9 Million
346,744
346,744 $40.5 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.